PURPOSE: Glucocorticoids are widely used as adjuvant therapy in hormonal refractory prostate cancer; their therapeutic role, however, remains unclear. Ursolic acid, a natural triterpene, structurally similar to dexamethasone, exhibits antitumor effects in various cell types. Our main objective was to investigate the effects of ursolic acid on cell viability, apoptosis and bcl-2 protein, in human hormone refractory and androgen-sensitive prostate cancer cells. METHODS: The ursolic acid-induced changes in cell viability, apoptosis and bcl-2 protein were examined in human hormone refractory prostate cancer PC-3 cells and androgen-sensitive LNCaP cells, by MTT assay, flow cytometry and western blot analysis, respectively. RESULTS: Ursolic acid inhibited significantly the cell viability and induced apoptosis in PC-3 cells at 55 microM and in LNCaP cells at 45 microM associated with a downregulation of bcl-2 protein. CONCLUSIONS: The antiproliferative and apoptotic effects of ursolic acid in PC-3 and LNCaP cells implicate its potential therapeutic use for the treatment of hormone refractory and androgen-sensitive prostate cancer. The downregulation of bcl-2 may be one of the molecular mechanisms via which it induces apoptosis in PC-3 and LNCaP cells.
PURPOSE: Glucocorticoids are widely used as adjuvant therapy in hormonal refractory prostate cancer; their therapeutic role, however, remains unclear. Ursolic acid, a natural triterpene, structurally similar to dexamethasone, exhibits antitumor effects in various cell types. Our main objective was to investigate the effects of ursolic acid on cell viability, apoptosis and bcl-2 protein, in human hormone refractory and androgen-sensitive prostate cancer cells. METHODS: The ursolic acid-induced changes in cell viability, apoptosis and bcl-2 protein were examined in human hormone refractory prostate cancer PC-3 cells and androgen-sensitive LNCaP cells, by MTT assay, flow cytometry and western blot analysis, respectively. RESULTS: Ursolic acid inhibited significantly the cell viability and induced apoptosis in PC-3 cells at 55 microM and in LNCaP cells at 45 microM associated with a downregulation of bcl-2 protein. CONCLUSIONS: The antiproliferative and apoptotic effects of ursolic acid in PC-3 and LNCaP cells implicate its potential therapeutic use for the treatment of hormone refractory and androgen-sensitive prostate cancer. The downregulation of bcl-2 may be one of the molecular mechanisms via which it induces apoptosis in PC-3 and LNCaP cells.
Authors: C B Cleutjens; K Steketee; C C van Eekelen; J A van der Korput; A O Brinkmann; J Trapman Journal: Endocrinology Date: 1997-12 Impact factor: 4.736
Authors: Michael Koutsilieris; Constantine S Mitsiades; John Bogdanos; Theodoros Dimopoulos; Dimitrios Karamanolakis; Constantine Milathianakis; Athanassios Tsintavis Journal: Clin Cancer Res Date: 2004-07-01 Impact factor: 12.531
Authors: W K Kelly; H I Scher; M Mazumdar; D Pfister; T Curley; C Leibertz; L Cohen; V Vlamis; A Dnistrian; M Schwartz Journal: J Clin Oncol Date: 1995-09 Impact factor: 44.544
Authors: Luis Fernando Méndez-López; Pierluigi Caboni; Eder Arredondo-Espinoza; Juan J J Carrizales-Castillo; Isaías Balderas-Rentería; María Del Rayo Camacho-Corona Journal: Molecules Date: 2021-04-11 Impact factor: 4.411
Authors: Magdalena C Kowalczyk; Jacob J Junco; Piotr Kowalczyk; Olga Tolstykh; Margaret Hanausek; Thomas J Slaga; Zbigniew Walaszek Journal: Int J Oncol Date: 2013-07-05 Impact factor: 5.650